Apocynoside I is primarily studied for its potential cardiovascular effects, particularly its ability to influence blood pressure regulation. It has demonstrated vasorelaxant properties in preclinical studies, suggesting possible use in managing hypertension. The compound may act by modulating vascular smooth muscle tone through interaction with nitric oxide pathways or calcium channels. Additionally, it has shown mild diuretic activity, which can support its antihypertensive effects by reducing blood volume. Research also indicates anti-inflammatory and antioxidant properties, which could contribute to protecting blood vessels from endothelial damage and atherosclerosis. While still in early experimental stages, these applications highlight its potential as a lead compound for developing natural product-based therapies for cardiovascular diseases.